SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Similar documents
Summary of the latest data on antibiotic resistance in the European Union

Multi-Drug Resistant Organisms (MDRO)

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

Is biocide resistance already a clinical problem?

Two (II) Upon signature

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Problem: Hospital Acquired Infections

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Tel: Fax:

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

The Hospital Environment as a Source of Resistant Gram Negatives

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

WHY IS THIS IMPORTANT?

A solution for current veterinary challenges

Overview of Infection Control and Prevention

Cipro for gram positive cocci in urine

Antimicrobial Copper Touch Surfaces: A new tool for Infection Control and Prevention

A Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital

AMR epidemiological situation: ECDC update

Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Risk of organism acquisition from prior room occupants: A systematic review and meta analysis

Testimony of the Natural Resources Defense Council on Senate Bill 785

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Antibacterial Agents & Conditions. Stijn van der Veen

Antimicrobial Resistance

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

CAVICIDE1. Technical Bulletin

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

Antimicrobial resistance (EARS-Net)

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

New Drugs for Bad Bugs- Statewide Antibiogram

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

New and Innovative Applications for Metals COPPER. Tony Lea International Copper Association

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

Antimicrobial and toxicological profile of the new biocide Akacid plus Ò

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Service Delivery and Safety Department World Health Organization, Headquarters

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Animal Antibiotic Use and Public Health

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

Infection Control & Prevention

Hospital Acquired Infections in the Era of Antimicrobial Resistance

VCU study suggests antimicrobial scrubs may reduce bacteria May also help decrease risk of MRSA transmission to patients

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

Randall Singer, DVM, MPVM, PhD

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Epidemiology and Economics of Antibiotic Resistance

Human health impacts of antibiotic use in animal agriculture

Multidrug Resistant Bacteria in 200 Patients of Moroccan Hospital

DO NOT WRITE ON or THROW AWAY THIS PAPER!

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

The importance of infection control in the era of multi drug resistance

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

MICRO-ORGANISMS by COMPANY PROFILE

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.

Epidemiology and Microbiology of Surgical Wound Infections

against Clinical Isolates of Gram-Positive Bacteria

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

An Approach to Linezolid and Vancomycin against Methicillin Resistant Staphylococcus Aureus

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

RCH antibiotic susceptibility data

Horizontal vs Vertical Infection Control Strategies

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials

What is the problem? Latest data on antibiotic resistance

running head: SUPERBUGS Humphreys 1

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

99.999% KILLS UP TO. MICROBES to help prevent healthcare-associated Infections

The University of Chicago Press The Society for Healthcare Epidemiology of America

ESCMID Online Lecture Library. by author

Antimicrobial Stewardship Strategy: Antibiograms

Transcription:

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS Adrienn Hanczvikkel 1, András Vígh 2, Ákos Tóth 3,4 1 Óbuda University, Budapest, Hungary 2 Department of Organic Chemistry and Technology, BUTE, Budapest, Hungary 3 National Center for Epidemiology, Budapest, Hungary 4 European Program for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden Corresponding author: Adrienn Hanczvikkel; hanczvikkel.a@gmail.com Introduction Healthcare Associated Infections (HAIs) present a global public health problem. [1] HAIs are often caused by high risk bacteria, which are adapted to the extreme environment of health institutions. Abiotic surfaces contaminated with such strains can contribute to the transmission of hospital pathogens and can be the sources of nosocomial infections and outbreaks. [2, 3] Fabrics in contact with patients can be important sources of pathogens. Surfaces finished with antimicrobial agents may help in the elimination of microorganisms. [4, 5] Our goal was to examine the survival capability of the most important aerobic, multidrug resistant, nosocomial bacteria on 100% cotton sheet separately treated with two commercially available antimicrobial agents. We chose four bacterial species, which are important and frequent pathogens in Hungarian hospitals, and also cause public health concern worldwide. Materials and methods We examined 10 representative strains each of VRE (i.e., vancomycin-resistant Enterococcus faecium), MRSA (i.e., methicillin-resistant Staphylococcus aureus), MACI (i.e., multidrug-resistant Acinetobacter baumannii), and MRKP (i.e., multidrugresistant Klebsiella pneumoniae). We used 100% cotton sheet treated with Sanitized T99-19 (50 m/m% dimethyltetradecyl (3-(trimethoxysilyl)propyl)ammonium-chloride) or Sanitized T27-22 Silver liquid (2 m/m% AgCl and 8 m/m% TiO2), according to the manufacturer s (Sanitized AG) instructions. 105-106 CFU (colony forming unit) were inoculated onto surfaces of untreated and two kinds of treated swatches. The samples were incubated at 25 C, and 52% RH. 3 strains of each species were examined in the detailed surviving study. The surviving capability (CFU of surviving bacteria) were established immediately after inoculation, drying, one hour and one day. Based on these results, we chose incubation times for additional 7 strains of each species (MRKP: one hour; MRSA, VRE, MACI: one hour, one day).

Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values were determined for Sanitized liquids by broth microdilution method. We used IBM SPSS Statistics Data Editor, One-Way ANOVA model and dependent t- test for paired samples to perform the statistical tests. Results and discussion The surviving capabilities were compared on untreated fabric for 10 strains of each species. The mean CFUs showed an increasing trend in the following order: MRKP < MRSA < VRE MACI. After one day MACI and VRE retained their viability significantly better than MRSA strains (P<0.01 and P=0.012, respectively). This is consistent with other literature data. [6, 7] Both antibacterial agents proved to be bactericide regarding all 40 examined pathogens, but Gram-negative species (MRKP, MACI) can tolerate significantly higher concentration of T99-19 and also of Silver liquid (P<0.01) than Gram-positive ones (MRSA, VRE). Figure 1 shows the results of the detailed surviving study with 3 strains of each species on untreated and on treated textiles. The Silver agent reduced the CFU of Gram-positive strains even during drying. After one hour only 1 VRE isolate was recoverable. T99-19 also reduced the CFU of Gram-positive bacteria, but 2 MRSA and 3 VRE strains were recoverable even after one day incubation. The antibacterial agents were less effective against the Gram-negative isolates. Figure 1. The surviving ability with standard deviation rate of the three strains per species. X-axis shows the CFU of surviving bacteria, y-axis shows the incubation times. Figure 2 shows the results of comprehensive surviving test with 10 strains of each species on untreated and on treated textiles. The Silver liquid treated fabric reduced the CFU of Gram-positive strains significantly (P<0.01). The T99-19 agent also

reduced the CFU of VRE and MRSA bacteria, but 9 VRE and 6 MRSA strains were recoverable even after one day incubation. Regarding Gram-negative bacteria antibacterial coatings proved to be effective only against MACI isolates (after one hour P<0.01), but despite of this all MACI strains were recoverable. No correlation was found between MIC or MBC values and the survival capability on textiles finished with antimicrobial agents. According to our results surviving capability of the strains on antimicrobial surfaces is not predictable based on MIC and MBC values. Figure 2. The surviving ability of 10 strains per species on untreated and on treated textiles after one hour incubation time. Statistical tests: dependent t-test for paired samples. Conclusion Silver liquid proved to be effective against Gram-positive bacteria. 18 strains from the examined 20 were destroyed on the sheet finished with Silver agent after one hour. Although T99-19 liquid also reduced the number of surviving bacteria significantly, 15 strains preserved their viability after one day incubation time. None of the antimicrobial agents were able to destroy the Gram-negative strains on the swatches. MRKP strains are well-known for their ability to accumulate and transfer drug-resistance determinants, and to cause epidemics, so despite being less viable on dry surfaces, these microorganisms can pose health risk in hospitals. The tolerance of MACI isolates against desiccation and antibacterial agents may contribute to their recently observed success in HAIs. REFERENCES 1. ECDC, Annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections. 2015 Stockholm.

2. Weinstein, R.A. and B. Hota, Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clinical infectious diseases, 2004. 39(8): p. 1182-1189. 3. Otter, J.A., et al., Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. American journal of infection control, 2013. 41(5): p. S6-S11. 4. Sondi, I. and B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. Journal of colloid and interface science, 2004. 275(1): p. 177-182. 5. Borkow, G. and J. Gabbay, Putting copper into action: copper-impregnated products with potent biocidal activities. The FASEB journal, 2004. 18(14): p. 1728-1730. 6. Wendt, C., et al., Survival of Acinetobacter baumannii on dry surfaces. Journal of Clinical Microbiology, 1997. 35(6): p. 1394-1397. 7. Neely, A.N. and M.P. Maley, Survival of enterococci and staphylococci on hospital fabrics and plastic. Journal of Clinical Microbiology, 2000. 38(2): p. 724-726.